BBS12 p.Ser20=
c.60A>G · rs759975718 · VCV698433
Computational evidence
| Protein change | ||
| Missense predictors do not apply to this variant type; conservation carries the signal. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
|---|---|---|
| Constraint at this position | ||
| Conservation | phyloP -0.7 | GERP -3.1 |
| Overall | ||
| CADD | 4.835 | PHRED · no single calibrated threshold — expert panels disagree |
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| European (non-Finnish)grpmax | 0.00873% | 11,456 |
| Remaining individualsnot grpmax-eligible | 0.0064% | 15,619 |
| African / African-American | 0.00267% | 37,458 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- BBS12
- Protein
- p.Ser20=
- Coding
- c.60A>G
- MANE Select
- NM_152618
- dbSNP
- rs759975718
- Type
- single nucleotide variant
- Location
- chr4:122741952 (GRCh38)
- Gene constraint
- LOEUF 1.419 · pLI <0.01 (gnomAD)
- Structure
- AlphaFold pLDDT 73.92
Disease context
Bardet-Biedl syndrome — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsFor Bardet-Biedl syndrome (Orphanet):
- Inheritance
- Autosomal recessive, Oligogenic
- Onset
- Antenatal, Childhood, Infancy, Neonatal
- Prevalence
- 1-9 / 100 000 (Specific population)
Similar variants
- BBS12 p.Ser20fs Pathogenic ★ same residue
- BBS12 p.Ala289Pro Likely pathogenic ★★ same condition
- BBS12 p.Arg214Ter Pathogenic/Likely pathogenic ★★ same condition
- BBS12 p.Arg355Ter Pathogenic ★★ same condition
- BBS12 p.Arg675Ter Pathogenic/Likely pathogenic ★★ same condition
- BBS12 p.Gln149Ter Pathogenic/Likely pathogenic ★★ same condition
- BBS12 p.Gln228Ter Pathogenic/Likely pathogenic ★★ same condition
- BBS12 p.Gln300Ter Pathogenic ★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/bbs12-p-ser20 (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown